SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.69-4.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (7836)11/25/1998 1:02:00 PM
From: aknahow  Read Replies (1) of 17367
 
Did you anticipate the return of the surficant issue?

From the gram positive patent:

In addition, the invention provides a method of killing or inhibiting growth of gram-positive bacteria comprising
contacting the bacteria with a BPI protein product alone, or in combination with another antibacterial agent. This method
can be practiced in vivo or in a variety of in vitro uses such as use in food preparation, to decontaminate fluids and
surfaces or to sterilize surgical and other medical equipment and implantable devices, including prosthetic joints. These
methods can correspondingly be used for in situ sterilization of indwelling invasive devices such as intravenous lines
and catheters, which are often foci of infection, or for sterilization of in vitro tissue colture media.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News